Psoriatic Arthritis
From the Journals
Spesolimab speeds lesion clearance in generalized pustular psoriasis
Patients treated with intravenous spesolimab showed significant clearance, but also susceptibility to infections.
Latest News
New option for flares in pustular psoriasis
Spesolimab earns Priority Review status from the FDA for treatment of flares in generalized pustular psoriasis.
News from the FDA/CDC
Upadacitinib (Rinvoq) gains psoriatic arthritis as second FDA-approved indication
The drug was previously approved for rheumatoid arthritis.
From the Journals
Guselkumab’s efficacy, safety confirmed in patients with psoriatic arthritis and prior TNFi exposure
COSMOS trial results in patients with psoriatic arthritis fit with the expectation that “people who’ve previously failed a TNF inhibitor might be...